EUVIMEDEUVIMED entdecken
Crossref

PEGylated Nanoliposomal Doxorubicin Conjugated with Specific TREM2 Peptides for Glioma‐Targeting Therapy

Hongyan Li iD, Duling Xu, Weihua Cai, Jiadi Liu, Zhitong Bing, Qiyue Zhang

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202403096 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Hongyan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Physics, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 730000, China. Hauptthemen laut MEDLINE: Doxorubicin, Glioma, Polyethylene Glycols, Peptides. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Natural Science Foundation for Distinguished Young Scholars of Gansu Province, Western Young Scholars Program of Chinese Academy of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PEGylated liposomes can deliver anti‐cancer drugs to brain tumors, and achieve enhanced permeability and retention effects. Triggering receptor expressed on myeloid cells 2 (TREM2) is an excellent biomarker for precise therapy of glioma. The present study is aimed at designing PEGylated nanoliposomal doxorubicin (PLD) conjugated with peptides targeting TREM2 for glioma‐targeting therapy. The specific peptides are designed with the Rosetta Peptiderive Protocol. Schrodinger's peptide‐specific version of Glide is used for molecular docking. PLD modified with peptides (peptide‐PLD) are engineered and prepared. Cell cycle, apoptosis, cell invasion and migration, cell viability, and colony‐formation assays are performed to analyze glioma cell functions. The anti‐tumor effects of peptide‐PLD are validated in an intracranial U87‐MG cells orthotopic glioma model. The targeting peptides HLRKLRKR and LRKLRLRL showed specific affinity for TREM2 and better cellular uptake in U87‐MG cells. PLD with peptide modification demonstrated stable doxorubicin loading, small sizes (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinGliomaPolyethylene GlycolsPeptidesMembrane GlycoproteinsReceptors, ImmunologicBrain NeoplasmsNanoparticlesAnimalsHumansCell Line, TumorMiceApoptosisLiposomesCell MovementMice, NudeCell Survival

Stichwörter der Autor:innen

PEGylated nanoliposomal doxorubicindrug delivery carrierglioma‐targeting therapytarget peptide

Substanzen

DoxorubicinPolyethylene GlycolsPeptidesMembrane GlycoproteinsReceptors, ImmunologicTREM2 protein, humanLiposomesliposomal doxorubicin

Autor:innen und Institutionen

  • Department of Medical Physics, Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, 730000, China.
  • Gansu Provincial Isotope Laboratory, Lanzhou, 730300, China.
  • Key Laboratory of Basic Research on Heavy Ion Radiation Application in Medicine, Lanzhou, 730000, China.
  • School of Nuclear Science and Technology, University of Chinese Academy of Sciences, Beijing, 101408, China.
  • Advanced Energy Science and Technology Guangdong Laboratory, Huizhou, 516029, China.
  • Department of Nuclear Medicine & Laboratory of Clinical Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, 610041, China.

ORCID-Profile: Hongyan Li

Förderung

  • Natural Science Foundation for Distinguished Young Scholars of Gansu Province
  • Western Young Scholars Program of Chinese Academy of Science

Zitieren

APA

Li, H., Xu, D., Cai, W., Liu, J., Bing, Z., & Zhang, Q. (2025). PEGylated Nanoliposomal Doxorubicin Conjugated with Specific TREM2 Peptides for Glioma‐Targeting Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202403096

Vancouver

Li H, Xu D, Cai W, Liu J, Bing Z, Zhang Q. PEGylated Nanoliposomal Doxorubicin Conjugated with Specific TREM2 Peptides for Glioma‐Targeting Therapy. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202403096

BibTeX
@article{Li2025,
  author = {Li, Hongyan and Xu, Duling and Cai, Weihua and Liu, Jiadi and Bing, Zhitong and Zhang, Qiyue},
  title = {PEGylated Nanoliposomal Doxorubicin Conjugated with Specific TREM2 Peptides for Glioma‐Targeting Therapy},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202403096}
}
Kostenlos starten →